Latest data from Philips reinforces the safety profile of Stellarex low-dose DCB - Vascular News
Stellarex | The Clear DCB Choice
Four-year results from patient-level meta-analysis confirm safety profile of Philips Stellarex 0.035 low-dose DCB - Vascular News
Stellarex BTK 0.014" Resources | Stellarex
ILLUMENATE Shows Favorable Outcomes at 4 Years with Stellarex Drug-Coated Balloon - CRTonline
Video : Live Case #12: PAOD CTO atherectomy + Stellarex® (Philips)
Philips Launches Two New Stellarex Drug-Coated Balloon Sizes - Medical Product Outsourcing
Philips to acquire cardiac device company Spectranetics for €1.9 billion
Stellarex Drug Coated Angioplasty Balloons – Vascupedia
Covidien deals Stellarex balloon to Spectranetics for $30m - MassDevice
mnhuon@baylismedical.com (@HuonNeumann) / Twitter
2 Trials Support Safety of Philips' Stellarex DCB | mddionline.com
CIS is First in Louisiana to Use Longer Drug-Coated Balloons
Stellarex Drug-coated 0.035" angioplasty balloon | Philips Healthcare
Philips Introduces New 200mm and 150mm Stellarex 0.035-inch Low-dose Drug-coated Balloons | DAIC
Five-year ILLUMENATE results confirm safety profile of Philips Stellarex DCB - Interventional News
Stellarex Drug-coated 0.035" angioplasty balloon | Philips Healthcare
FDA approves Philips' low-dose Stellarex balloons - Drug Delivery Business
Philips Fulfills a Prophecy with $2.2B Spectranetics Deal | mddionline.com
Stellarex Drug-coated 0.035" angioplasty balloon | Philips Healthcare
Stellarex Drug-coated 0.035" angioplasty balloon | Philips Healthcare
